semaglutide patent novo nordisk Takes Telehealth Company to Court Over Knockoffs Novo Nordisk patent expiry opens

Discussion The main objective of these studies is to evaluate the therapeutic potential of GLP-1 agonists in MS management

Drug repositioning Drug repositioning is an alternative approach to identify new fields of application for existing drugs, currently approved for a different clinical condition

Ulrich and Jakob, 2019

Transformed lives through weight loss and glucose control, contrasted with lives forever changed by vision loss

Medical research shows that abrupt cessation differs significantly from planned dose reduction, making the decision to stop GLP-1 therapy one that requires careful clinical consideration rather than an immediate halt